Form D · Biotechnology
Osmetech PLC
Pasadena, CA · CIK 0001369655
Offering snapshot reported Dec 22, 2009 · SEC filing
- Reported sold
- $8.56M Offering amount: $8.56M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2009 | Initial | $8,555,000 | No comparison | 21 | SEC filing |
| Jul 6, 2009 | Initial | $6,250,000 | No comparison | 12 | SEC filing |
| Dec 18, 2008 | Initial | $5,000,000 | No comparison | Not reported | SEC filing |
| Jul 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-92048
Source: Form D, filed Dec 22, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daryl J. Faulkner | Director |
| Christopher Gleeson | Director |
| Gordon James Hall | Director |
| Jon Faiz Kayyem | Director |
| Gordon Bruce Kuenstor | Director |
| Mark Paul Lappe | Director |
| David Anthony Sandilands | Director, Executive |
| James Nicholas Gerald White | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Osmetech Inc. 757 S. Raymond Avenue
Pasadena, CA, 91105
Pasadena, CA, 91105